ConductScience.org, home

Paper39770554

ANN-QSAR, Molecular Docking, ADMET Predictions, and Molecular Dynamics Studies of Isothiazole Derivatives to Design New and Selective Inhibitors of HCV Polymerase NS5B.

Fattouche M and 8 others. Pharmaceuticals (Basel), 2024. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. ANN-QSAR, Molecular Docking, ADMET Predictions, and Molecular Dynamics Studies of Isothiazole Derivatives to Design New and Selective Inhibitors of HCV Polymerase NS5B. Papers, record 39770554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39770554

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
ANN-QSAR, Molecular Docking, ADMET Predictions, and Molecular Dynamics Studies of Isothiazole Derivatives to Design New and Selective Inhibitors of HCV Polymerase NS5B.
PubMed
Journal
Pharmaceuticals (Basel)
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.88, provisional
iCite
Revised in PubMed
2025-01-08
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fattouche MMaroua
2Belaidi SSalah
3Abchir OOussamahttps://orcid.org/0000-0001-9183-6951
4Al-Shaar WWalid
5Younes KKhaledhttps://orcid.org/0000-0003-0966-2433
6Al-Mogren MMMuneerah Mogren
7Chtita SSamirhttps://orcid.org/0000-0003-2344-5101
8Soualmia FFatima
9Hochlaf MMajdihttps://orcid.org/0000-0002-4737-7978

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
NOT AVAILABLEAmerican University of the Middle EastPubMed

Source PubMed

Download CSV of grants

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135352175Design of novel benzimidazole derivatives as potential α-amylase inhibitors using QSAR, pharmacokinetics, molecular docking, and molecular dynamics simulation studies.J Mol Model2022https://conductscience.org/library/papers/35352175PubMed
228256516SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules.Sci Rep2017https://conductscience.org/library/papers/28256516PubMed
323299630Some case studies on application of "r(m)2" metrics for judging quality of quantitative structure-activity relationship predictions: emphasis on scaling of response data.J Comput Chem2013https://conductscience.org/library/papers/23299630PubMed
432964807Multi-combined 3D-QSAR, docking molecular and ADMET prediction of 5-azaindazole derivatives as LRRK2 tyrosine kinase inhibitors.J Biomol Struct Dyn2022https://conductscience.org/library/papers/32964807PubMed
510746014A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases.J Comb Chem1999https://conductscience.org/library/papers/10746014PubMed
619709881Non-nucleoside inhibitors of HCV polymerase NS5B. Part 4: structure-based design, synthesis, and biological evaluation of benzo[d]isothiazole-1,1-dioxides.Bioorg Med Chem Lett2009https://conductscience.org/library/papers/19709881PubMed
711858635Beware of q2!J Mol Graph Model2002https://conductscience.org/library/papers/11858635PubMed
817599350Predicting absolute ligand binding free energies to a simple model site.J Mol Biol2007https://conductscience.org/library/papers/17599350PubMed
912036371Molecular properties that influence the oral bioavailability of drug candidates.J Med Chem2002https://conductscience.org/library/papers/12036371PubMed
109504803SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling.Electrophoresis1997https://conductscience.org/library/papers/9504803PubMed
1134918764QSAR Studies and Structure Property/Activity Relationships Applied in Pyrazine Derivatives as Antiproliferative Agents Against the BGC823.Acta Chim Slov2021https://conductscience.org/library/papers/34918764PubMed
1219399780AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.J Comput Chem2009https://conductscience.org/library/papers/19399780PubMed
13282738842D-QSAR and 3D-QSAR/CoMSIA Studies on a Series of (R)-2-((2-(1H-Indol-2-yl)ethyl)amino)-1-Phenylethan-1-ol with Human β₃-Adrenergic Activity.Molecules2017https://conductscience.org/library/papers/28273884PubMed
1417049853Isothiazoles as active-site inhibitors of HCV NS5B polymerase.Bioorg Med Chem Lett2007https://conductscience.org/library/papers/17049853PubMed
1511259830Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.Adv Drug Deliv Rev2001https://conductscience.org/library/papers/11259830PubMed
1633558778QSAR study of unsymmetrical aromatic disulfides as potent avian SARS-CoV main protease inhibitors using quantum chemical descriptors and statistical methods.Chemometr Intell Lab Syst2021https://conductscience.org/library/papers/33558778PubMed
1727463326Best Practices for QSAR Model Development, Validation, and Exploitation.Mol Inform2010https://conductscience.org/library/papers/27463326PubMed
1827108770Comprehensive evaluation of ten docking programs on a diverse set of protein-ligand complexes: the prediction accuracy of sampling power and scoring power.Phys Chem Chem Phys2016https://conductscience.org/library/papers/27108770PubMed
1936947906
Parsing structural fragments of thiazolidin-4-one based α-amylase inhibitors: A combined approach employing in vitro colorimetric screening and GA-MLR based QSAR modelling supported by molecular docking, molecular dynamics simulation and ADMET studies.
Comput Biol Med2023https://conductscience.org/library/papers/36947906PubMed
2037966948Structure-based virtual screening, ADMET analysis, and molecular dynamics simulation of Moroccan natural compounds as candidates for the SARS-CoV-2 inhibitors.Nat Prod Res2024https://conductscience.org/library/papers/37966948PubMed

See all 25 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
42280532Machine Learning-Based Prediction of Polymer Properties Using Structure-Property Relationship Modeling.Polymers (Basel)2026https://conductscience.org/library/papers/42280532

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39770554

GET https://conductscience.org/api/papers/v1/39770554/references?page=2